Department of Pathology, The Second Hospital of Jilin University, Changchun No.218 Ziqiang Street, Jilin, China.
Department of Radiotherapy, The Second Hospital of Jilin University, Changchun No.218 Ziqiang Street, Jilin, China.
Biomed Pharmacother. 2022 Feb;146:112608. doi: 10.1016/j.biopha.2021.112608. Epub 2021 Dec 28.
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). On behalf of all authors, the corresponding author, Jiannan Li, is retracting the above article. The authors informed the journal that they mistakenly provided inappropriate H&E and EGFR immunohistochemical images for the Rg3-NPs group in Fig. 9 of the published article. The results in Fig. 9D cannot be reproduced as originally published. Importantly, in the present version, Rg3-NPs groups do not show an EGFR promotion effect compared to Rg3 and Cimetidine groups. Therefore, their final results and conclusions are not supported. The authors sincerely apologise to the editors and journal readership for these oversights and inconvenience that this may have caused.
请参阅 Elsevier 关于文章撤回政策(http://www.elsevier.com/locate/withdrawalpolicy)。代表所有作者,通讯作者李建南正在撤回上述文章。作者告知期刊,他们在已发表文章的图 9 中错误地提供了 Rg3-NPs 组的不合适的 H&E 和 EGFR 免疫组化图像。图 9D 中的结果无法按原样重现。重要的是,在目前的版本中,与 Rg3 和西咪替丁组相比,Rg3-NPs 组并没有显示出 EGFR 促进作用。因此,他们的最终结果和结论没有得到支持。作者为此疏忽和可能由此造成的不便向编辑和期刊读者真诚道歉。